Alternatives to Impact Biotech

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Biotechnology company developing novel therapies for multiple myeloma.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Compressing biology to develop the next generation of therapies.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.